CIK 0001527352 · <br>Emerging growth company
Nexalin Technology, Inc.
Sign in to watch- Ticker
- NXL
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275566468
- Phone
- (832) 260-0222
- Business address
- 1776 YORKTOWN, SUITE 550, HOUSTON, TX, 77056
- 4/A Open-market buy President/CEO bought 25,000 shares at $4.15 ($103,750)
- 8-K/A Event Material agreement · Other events
- 8-K Event Material agreement · Other events
- 4 Open-market buy Ms. Elson serves as CFO bought 36,000 shares at $4.15 ($149,400)
- 4 Open-market buy Director bought 2,500 shares at $4.15 ($10,375)
- 4 Open-market buy Director bought 2,500 shares at $4.15 ($10,375)
- 4 Open-market buy Chief Medical Officer bought 2,500 shares at $4.15 ($10,375)
- 4 Open-market buy President/CEO bought 2,500 shares at $4.15 ($10,375)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 424B4 Offering Prospectus
- 8-K Event Material agreement · Other events
- CERT Other Certification
- EFFECT Other Notice of Effectiveness
- S-1/A Offering Registration Statement
- S-1/A Offering Registration Statement
Page 9 of 11 · 206 filings